Back
BridgeBio Pharma Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
BBIO
BridgeBio Pharma
Last Price:
$46.54
Seasonality Move:
10.52%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and BBIO is experiencing slight selling pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.72 | Sell |
20-day SMA: | 44.8 | Buy |
50-day SMA: | 39.54 | Buy |
200-day SMA: | 32.64 | Buy |
8-day EMA: | 46.31 | Buy |
20-day EMA: | 44.55 | Buy |
50-day EMA: | 41.1 | Buy |
200-day EMA: | 34.6 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 66.23 | Buy |
Chaikin Money Flow: | -829469 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.39 - 46.33) | Buy |
Bollinger Bands (100): | (32.42 - 41.54) | Buy |
BridgeBio Pharma Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 46.51 while BBIO 8-day simple moving average is 46.72, which is a Sell signal.
-
The stock price of BBIO is 46.51 while BridgeBio Pharma 20-day SMA is 44.80, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 39.54 while BBIO share price is 46.51, making it a Buy technically.
-
BBIO stock price is 46.51 and BridgeBio Pharma 200-day simple moving average is 32.64, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
44
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $46.51. The Score for BBIO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
8.8B
Price in USD:
46.51
Share Volume:
2.1M
BridgeBio Pharma 52-Week Range
52-Week High:
48.68
52-Week Low:
21.72
Sell
44
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 46.51 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 46.51 while BBIO 8-day exponential moving average is 46.31, which is a Buy signal.
-
The stock price of BBIO is 46.51 while BridgeBio Pharma 20-day EMA is 44.55, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 41.10 while BBIO share price is 46.51, making it a Buy technically.
-
BBIO stock price is 46.51 and BridgeBio Pharma 200-day simple moving average is 34.60, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.19 per share, an increase this year of $0.17 per share, and an increase next year of $0.55 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 2.06, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 66.23, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (41.39 - 46.33), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (32.42 - 41.54), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.